Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Comment by skiptoggleon Jun 26, 2018 6:16pm
141 Views
Post# 28233150

RE:RE:RE:RE:RBC

RE:RE:RE:RE:RBCReading into RBC's analysis they think BBI will not have the earnings to fund the 2019 capital requirements nor will they secure financing.  Again this is a conservative outlook.

The next two quarters will determine whether they can pump enough product consistently and or secure a larger loan.  Another option would be to farm out more locations and get additional $$ or if they do monetize Stage in some form or another.

One other thing to note RBC did not evaluate the possibility of tapping into the DOIG or Lower Montney Zones.

risk53 wrote:
 
........ A few more shares doesn’t fit the context of the quote ...Count me in as one who is clueless as I am holding Garth to his word that dilution will not be necessary. And I will continue to trust him at his word until he proves me wrong



Bullboard Posts